MIRIAM GAFFER FERREIRA: Open Payments
NPI 1013230440 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,488 in 202 payments from 19 companies in 2025. Trend: 2023 $1,829 · 2024 $3,624 · 2025 $4,488
Food & beverage: $4,209Education: $279
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 34 | $824 |
| LEO Pharma Inc. | 36 | $504 |
| Incyte Corporation | 20 | $395 |
| Galderma Laboratories, L.P. | 12 | $375 |
| Lilly USA, LLC | 13 | $333 |
| Arcutis Biotherapeutics, Inc. | 15 | $278 |
| GENZYME CORPORATION | 10 | $261 |
| ABBVIE INC. | 14 | $255 |
| UCB, Inc. | 9 | $217 |
| Organon LLC | 9 | $196 |
Products named: CIBINQO, ADBRY, DUPIXENT, OPZELURA, NEMLUVIO, LITFULO, TALTZ, Zoryve.
Industry payments across CA — which companies pay providers there.
